Across TCGA pan-cancer cohorts, TVP23BP1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of TVP23BP1’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where TVP23BP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TVP23BP1 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.
THCA, PRAD, and KIRC are the cancer types where TVP23BP1 tumor–normal differential expression is most reproducible.